Get started
Author

Luca Lalli

Observed names: L. Lalli, Lalli, Luca
ORCID: 0000-0002-4472-628X
Observed ORCID: 0000-0002-4472-628X
OpenAlex ID: A5006090996
Fasting-Mimicking Diet Is Safe and Reshapes Metabolism and Antitumor Immunity in Patients with Cancer
2021 · Claudio Vernieri, Giovanni Fucà, et al. · Cancer Discovery · 341
PDF
Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma
2018 · Veronica Huber, Viviana Vallacchi, et al. · Journal of Clinical Investigation · 266
PDF
Peripherally inserted central catheters (PICCs) in cancer patients under chemotherapy: A prospective study on the incidence of complications and overall failures
2016 · Sergio Bertoglio, Beatrice Faccini, et al. · Journal of Surgical Oncology · 144
Long-term Efficacy of Methotrexate Plus Vinblastine/Vinorelbine in a Large Series of Patients Affected by Desmoid-Type Fibromatosis
2017 · Elena Palassini, Anna Maria Frezza, et al. · The Cancer Journal · 95
Cabozantinib as First-line Treatment in Patients With Metastatic Collecting Duct Renal Cell Carcinoma: Results of the BONSAI Trial for the Italian Network for Research in Urologic-Oncology (Meet-URO 2 Study)
2022 · Giuseppe Procopio, Pierangela Sepe, et al. · JAMA Oncology · 66
Extracellular vesicles in anti-tumor immunity
2021 · Elisabetta Vergani, Elena Daveri, et al. · Seminars in Cancer Biology · 58
PDF
Development of a Nomogram Predicting the Risk of Persistence/Recurrence of Cervical Dysplasia
2022 · Giorgio Bogani, Luca Lalli, et al. · Vaccines · 55
PDF
Sentinel node mapping in high-intermediate and high-risk endometrial cancer: Analysis of 5-year oncologic outcomes
2024 · Ilaria Cuccu, Francesco Raspagliesi, et al. · European Journal of Surgical Oncology · 54
miR-146a-5p impairs melanoma resistance to kinase inhibitors by targeting COX2 and regulating NFkB-mediated inflammatory mediators
2020 · Elisabetta Vergani, Matteo Dugo, et al. · Cell Communication and Signaling · 41
PDF
Y 90 -radioembolisation in hepatocellular carcinoma induces immune responses calling for early treatment with multiple checkpoint blockers
2022 · Licia Rivoltini, Sherrie Bhoori, et al. · Gut · 40
PDF
The Fatty Acid and Protein Profiles of Circulating CD81-Positive Small Extracellular Vesicles Are Associated with Disease Stage in Melanoma Patients
2021 · Giovanni Paolino, Veronica Huber, et al. · Cancers · 34
PDF
Nutritional status and body composition assessment in patients with a new diagnosis of advanced solid tumour: Exploratory comparison of computed tomography and bioelectrical impedance analysis
2020 · A. Casirati, G. Vandoni, et al. · Clinical Nutrition · 33
Prognostic significance of HER2-low status in HR-positive/HER2-negative advanced breast cancer treated with CDK4/6 inhibitors
2023 · Emma Zattarin, Daniele Presti, et al. · npj Breast Cancer · 32
Predicting the Risk of nOdal disease with histological and Molecular features in Endometrial cancer: the prospective PROME trial
2024 · Giorgio Bogani, Luca Lalli, et al. · International Journal of Gynecological Cancer · 30
PDF
Back to simplicity: a four-marker blood cell score to quantify prognostically relevant myeloid cells in melanoma patients
2021 · Veronica Huber, Lorenza Di Guardo, et al. · Journal for ImmunoTherapy of Cancer · 19
PDF
Cancer-associated foam cells hamper protective T cell immunity and favor tumor progression in human colon carcinogenesis
2024 · Elena Daveri, Barbara Vergani, et al. · Journal for ImmunoTherapy of Cancer · 17
PDF
Efficacy of liver transplantation after response to atezolizumab-bevacizumab downstaging of intermediate and advanced hepatocellular carcinoma (ImmunoXXL)
2026 · Sherrie Bhoori, Licia Rivoltini, et al. · Journal of Hepatology · 16
Genetic Layout of Melanoma Lesions Is Associated with BRAF/MEK-Targeted Therapy Resistance and Transcriptional Profiles
2022 · Elisabetta Vergani, Adele Busico, et al. · Journal of Investigative Dermatology · 16
PDF
Potent natural killer (NK) and myeloid blood cell remodeling by cabozantinib (Cabo) in pre-treated metastatic renal cell carcinoma (mRCC) patients (pts)
2018 · E. Verzoni, S. Ferro, et al. · Annals of Oncology · 15
Integrated transcriptional‐phenotypic analysis captures systemic immunomodulation following antiangiogenic therapy in renal cell carcinoma patients
2021 · Darawan Rinchai, Elena Verzoni, et al. · Clinical and Translational Medicine · 11
PDF
Spatial distribution of tumour immune infiltrate predicts outcomes of patients with high-risk soft tissue sarcomas after neoadjuvant chemotherapy
2024 · Sandro Pasquali, Viviana Vallacchi, et al. · EBioMedicine · 10
Risk assessment of thromboembolic events in hospitalized cancer patients
2021 · Federico Nichetti, Francesca Ligorio, et al. · Scientific Reports · 10
PDF
Impact of Baseline and On-Treatment Glycemia on Everolimus-Exemestane Efficacy in Patients with Hormone Receptor–Positive Advanced Breast Cancer (EVERMET)
2021 · Claudio Vernieri, Federico Nichetti, et al. · Clinical Cancer Research · 10
PDF
FNA and CNB in the Diagnosis of Pulmonary Lesions: A Single-center Experience on 665 Patients, Comparison between Two Periods
2017 · Alfonso Vittorio Marchianò, Maria Cosentino, et al. · Tumori Journal · 9
Low baseline neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict increased overall survival in locally recurrent rectal cancer despite R1 margins
2022 · Elena Daveri, Luca Sorrentino, et al. · Digestive and Liver Disease · 6
Works count: 87
Citation count: 1,470
H-index: 16
I10-index: 23
Year
Topic
Type